Advancing Research to Improve Health During the Menopausal Transition—Agenda: Day 3

Friday, April 17, 2026
10:00 a.m. to 4:30 p.m. ET
Online Only

« Back to Workshop Page
«« See Day 1: April 15, 2026
« See Day 2: April 16, 2026

10:00 a.m.

Opening Remarks and Day 2 Recap

Cheryl Anderson, Ph.D., M.P.H., M.S
Workshop & Panel Chair

NIH Leadership Remarks

10:10 a.m.

National Institute of Mental Health

Andrea Beckel-Mitchener, Ph.D.
Acting Director, National Institute of Mental Health
National Institutes of Health

10:15 a.m.

National Heart, Lung, and Blood Institute

David Goff, M.D., Ph.D.
Acting Director, National Heart, Lung, and Blood Institute
National Institutes of Health

Key Question 2a:

What is the impact of individual-level factors on the receipt of treatment for perimenopausal and early postmenopausal women with symptoms? Individual-level factors include, but are not limited to, educational attainment, patient engagement in health care, lifestyle factors, and comorbidities.

10:20 a.m.

Moderator Perspectives: How Do Individual-Level Factors Influence the Likelihood of Perimenopausal and Early Postmenopausal Women with Symptoms Receiving Treatment?—Genevieve Neal-Perry, M.D., Ph.D.

10:30 a.m.

Closing the Menopause Care Gap: The Workforce Issue—Rajita G. Patil, M.D.

10:50 a.m.

Patient Education: Menopause Preparedness—Irene Aninye, Ph.D.

11:10 a.m.

Awareness/Communications—Jennifer Gunter, M.D

11:30 a.m.

It Takes a Village: Perspectives on Menopausal Care Empowerment, Advocacy, and Community Engagement—Genevieve Neal-Perry, M.D., Ph.D

11:50 a.m.

Discussion

Moderated by
Genevieve Neal-Perry, M.D., Ph.D.

12:10 p.m.

Lunch Break

Key Question 2b:

What is the impact of system-level factors on the receipt of treatment for perimenopausal and early postmenopausal women with symptoms? System-level factors include, but are not limited to, racism, provider bias, access to care, and social determinants of health. Do the effectiveness, comparative effectiveness, and harms of treatment vary by individual- or system-level factors?

12:40 p.m.

System-Level Challenges Affecting the Menopause Experience and Quality of Care for Midlife Women: Research Gaps and Reflections on Solutions—Andrea LaCroix, Ph.D.

1:00 p.m.

Regulatory Perspectives: Opportunities and Considerations—Janet Maynard, M.D.

1:20 p.m.

Social and Cultural Context of Menopause—Yamnia Cortes, Ph.D., M.P.H., R.N., FAHA, FAAN

1:40 p.m.

Discussion

Moderated by
Cheryl Anderson, Ph.D., M.P.H., M.S
Workshop & Panel Chair

2:00 p.m.

Break

General Session 3

Innovative Approaches to Symptom Prevention and Management: Walk Before We Run—Grounding Innovation in Evidence for Menopause Care

2:10 p.m.

Moderator Perspectives—Melissa S. Wong, M.D., M.H.D.S.

2:20 p.m.

Data Gaps & the DREAM Registry… and Other Data Sets—Stephanie S. Faubion, M.D., M.B.A.

2:35 p.m.

Women’s SexualHealth and Direct-to-Consumer Approaches—Lyndsey Harper, M.D.

2:50 p.m.

Health Policy and Digital Innovation Readiness—Barbara Levy, M.D., FACOG, FACS

3:05 p.m.

The Etiology of Online Medical Misinformation—Jevin West, Ph.D.

3:20 p.m.

Discussion

Moderated by
Melissa S. Wong, M.D., M.H.D.S.

3:40 p.m.

Break

3:50 p.m.

Roundtable on What We Learned, What Comes Next?

Moderated by
Sarah Temkin, M.D.

  • Nanette Santoro, M.D.
  • Karen Giblin
  • Genevieve Neal-Perry, M.D., Ph.D.
  • Melissa S. Wong, M.D., M.H.D.S.

4:20 p.m.

Closing Remarks & Next Steps

Cheryl Anderson, Ph.D., M.P.H., M.S
Workshop & Panel Chair

Keisha L. Shropshire, M.P.H.
P2P Workshop Coordinator

4:30 p.m.

Adjourn